Cooper Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Cooper Capital Advisors's LLY Position: Q3 2026 in Review
Cooper Capital Advisors held its Eli Lilly (LLY) position steady in Q3 2026 at 248 shares worth $287K. The position accounts for 0.12% of the portfolio, ranked #43.
Cooper Capital Advisors first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $297K in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Cooper Capital Advisors held 248 shares of Eli Lilly worth $287K as of Q3 2026.
- Cooper Capital Advisors left its Eli Lilly share count unchanged in Q3 2026.
- Eli Lilly made up 0.12% of Cooper Capital Advisors's portfolio in Q3 2026, its #43 holding.
- Cooper Capital Advisors first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
- Cooper Capital Advisors's Eli Lilly position peaked at $297K in Q2 2026.
- 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Cooper Capital Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.